Literature DB >> 11708392

The economic impact of autism in Britain.

K Järbrink1, M Knapp.   

Abstract

Little is known about the economic impact of autism. This study estimated the economic consequences of autism in the United Kingdom, based on published evidence and on the reanalysis of data holdings at the Centre for the Economics of Mental Health (CEMH). With an assumed prevalence of 5 per 10,000, the annual societal cost for the UK was estimated to exceed ł1 billion. The lifetime cost for a person with autism exceeded ł2.4 million. The main costs were for living support and day activities. Family costs account for only 2.3 percent of the total cost, but a lack of relevant information limited our ability to estimate these costs. Minor improvements in life outcome for people with autism could substantially reduce costs over the lifetime.

Entities:  

Mesh:

Year:  2001        PMID: 11708392     DOI: 10.1177/1362361301005001002

Source DB:  PubMed          Journal:  Autism        ISSN: 1362-3613


  41 in total

1.  Characteristics of children with autistic spectrum disorders served in comprehensive community-based mental health settings.

Authors:  David S Mandell; Christine M Walrath; Brigitte Manteuffel; Gina Sgro; Jennifer Pinto-Martin
Journal:  J Autism Dev Disord       Date:  2005-06

2.  In vivo 1H-magnetic resonance spectroscopy study of the attentional networks in autism.

Authors:  Silvia Bernardi; Evdokia Anagnostou; Jun Shen; Alexander Kolevzon; Joseph D Buxbaum; Eric Hollander; Patrick R Hof; Jin Fan
Journal:  Brain Res       Date:  2010-12-23       Impact factor: 3.252

3.  State infant/toddler program policies for eligibility and services provision for young children with autism.

Authors:  Aubyn C Stahmer; David S Mandell
Journal:  Adm Policy Ment Health       Date:  2007-01

4.  Aripiprazole in the treatment of challenging behaviour in adults with autism spectrum disorder.

Authors:  Iain Jordan; Dene Robertson; Marco Catani; Michael Craig; Declan Murphy
Journal:  Psychopharmacology (Berl)       Date:  2012-04-26       Impact factor: 4.530

5.  Factors associated with age of diagnosis among children with autism spectrum disorders.

Authors:  David S Mandell; Maytali M Novak; Cynthia D Zubritsky
Journal:  Pediatrics       Date:  2005-12       Impact factor: 7.124

6.  Health care expenditures for children with autism spectrum disorders in Medicaid.

Authors:  Li Wang; Douglas L Leslie
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2010-11       Impact factor: 8.829

7.  Medical expenditures for children with an autism spectrum disorder in a privately insured population.

Authors:  Tom T Shimabukuro; Scott D Grosse; Catherine Rice
Journal:  J Autism Dev Disord       Date:  2007-08-10

8.  The cost-effectiveness of expanding intensive behavioural intervention to all autistic children in Ontario: in the past year, several court cases have been brought against provincial governments to increase funding for Intensive Behavioural Intervention (IBI). This economic evaluation examines the costs and consequences of expanding an IBI program.

Authors:  Sanober S Motiwala; Shamali Gupta; Meredith B Lilly; Wendy J Ungar; Peter C Coyte
Journal:  Healthc Policy       Date:  2006-01

Review 9.  Autism: an emerging public health problem.

Authors:  Craig J Newschaffer; Laura Kresch Curran
Journal:  Public Health Rep       Date:  2003 Sep-Oct       Impact factor: 2.792

10.  Medicaid expenditures for children with autistic spectrum disorders: 1994 to 1999.

Authors:  David S Mandell; Jun Cao; Richard Ittenbach; Jennifer Pinto-Martin
Journal:  J Autism Dev Disord       Date:  2006-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.